Patently O

MARCH 4, 2024

For several years, Celanese kept its Ace-K manufacturing process a trade secret while selling the Ace-K product it produced. Historically, an inventor could choose to protect a new manufacturing process either by patenting it or by keeping it as a trade secret – but not both. Celanese appealed. Compare D.L. Auld Company v.

Manufacturing 40

Manufacturing Statute Healthcare Court 40

The Process Street

NOVEMBER 28, 2023

Applications of AI in healthcare Artificial intelligence in the healthcare industry has numerous applications that can improve patient care, diagnoses, and overall efficiency in the industry. And, while Google has led the way for a number of years , the power of machine learning is available to businesses of any size.

Virtual Assistant 105

Virtual Assistant Healthcare Entertainment Education 105

FDA Law Blog

SEPTEMBER 19, 2023

The six-page statement explains that “Brand drug manufacturers may be harming generic competition through the improper listing of patents in the. Of course, the statute says that only drug formulation, composition, or method of use patents are listable, but FDA has not defined the scope of the “drug” that must be covered by the patent.

Manufacturing 105

Manufacturing Statute Healthcare Litigation 105

Patently O

JULY 17, 2022

Instead, a generic manufacturer can sell its product with a “skinny label” that “carves out” any patented uses found in the brand drug’s labeling—and thereby avoid inducing infringement of the brand manufacturer’s patent rights. Caraco (2012). See 21 U.S.C. § 355(j)(2)(A)(viii). c)(2)(i)(O)(2), (c)(2)(i)(P)(2).

Manufacturing 60

Manufacturing Healthcare Court Statute 60

FDA Law Blog

APRIL 25, 2023

Shapiro — Does your firm manufacture a “cyber device”? Congress has given FDA the authority to require device manufacturers to provide cybersecurity information in their premarket submissions for a “cyber device.” Please refer to the help text in this section for the content that is required according to this statute.”

Laws 105

Laws Manufacturing Drafting Technology 105

FDA Law Blog

JUNE 16, 2023

Kirschenbaum — On May 24, Minnesota enacted the Commerce and Consumer Protection Omnibus Bill, Senate File 2744 ( SF 2744 ), which significantly expands the state’s existing drug pricing activities with serious implications for all drug manufacturers, and particularly generic drug manufacturers. We address each below. Best price?

Manufacturing 45

Manufacturing Calendaring Healthcare Statute 45

FDA Law Blog

DECEMBER 12, 2022

How could the manufacturers even follow this guidance without illegally departing from their previously approved labeling? There appears to be significant overlap in content between the Checklist and informed consent forms and processes routinely provided by healthcare providers to their patients. What is going on here? Draft Guidance.

Drafting 52

Drafting Manufacturing Legal Legal 52

FDA Law Blog

OCTOBER 6, 2023

The crux of the proposed rule lies in the addition of ten words: “ including when the manufacturer of these products is a laboratory.” These words would be added to the definition of “ in vitro diagnostic [IVD] products” in 21 C.F.R. But, by statute all devices not previously classified are automatically placed into Class III.

Manufacturing 64

Manufacturing Healthcare Drafting Statute 64

FDA Law Blog

AUGUST 8, 2024

Governors, state cannabis regulators, law enforcement groups and local governments weighed in, as did marijuana advocates and opponents, marijuana industry associations, Members of Congress, federal law enforcement groups, healthcare and human rights groups, unions and trade associations, and private individuals.

Healthcare 59

Healthcare Manufacturing Attorney Statute 59

FDA Law Blog

OCTOBER 12, 2022

Most states have some form of naloxone standing order that allows a healthcare provider to write a prescription that covers a large group of people rather than just an individual patient. For example, the Maryland standing order allows all Maryland licensed pharmacists to dispense naloxone, including any necessary sup??

Healthcare 52

Healthcare Manufacturing Statute 52

FDA Law Blog

MARCH 30, 2022

But if you limit a generic drug manufacturer’s ability to settle cases, that manufacturer does not settle fewer cases, it submits fewer Paragraph IV ANDAs. healthcare system. It could also address FDA’s concern about companies submitting ANDAs with non-compliant manufacturing facilities identified.

Manufacturing 40

Manufacturing Healthcare Government Statute 40

JURIST

NOVEMBER 7, 2023

This is not the first suit the government has filed related to pharmaceutical distributors’, manufacturers’ and pharmacies’ role in the opioid epidemic. Cencora has denied the allegations. Johnson & Johnson and Mallinckrodt.

Statute 221

Statute Manufacturing Government Court 221

Patently O

SEPTEMBER 26, 2022

The most anticipated case last year was the 101 eligibility petition regarding automobile drive shaft manufacturing process. Accord Healthcare, Inc., One way to think about this case is the level of responsibility that the generic manufacturer has to make sure that its drug is not used in an infringing way. 4th 1013 (Fed.

Court 126

Court Laws Manufacturing Statute 126

FDA Law Blog

SEPTEMBER 8, 2022

Recognizing the problems that high prescription drug costs pose to patient access to medications, many drug manufacturers have created copay assistance programs to help patients afford the copays and deductibles for their medications. These prohibitions are often referred to as copay accumulator adjustment programs.

Manufacturing 83

Manufacturing Statute Healthcare Court 83

Above The Law

MARCH 7, 2025

Justice Barrett : 929 words Justice Barretts questioning primarily sought to clarify legal nuances surrounding the conscience protections for healthcare workers, the standing of associations in legal challenges, and the implications of regulations related to abortion and its associated medical procedures.

Constitutional Law 105

Constitutional Law Laws Statute Legal 105